INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 140 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,595,000 | -35.5% | 282,128 | -17.4% | 0.00% | -25.0% |
Q3 2016 | $4,025,000 | +11.2% | 341,389 | +22.1% | 0.00% | 0.0% |
Q2 2016 | $3,619,000 | -11.0% | 279,631 | +9.9% | 0.00% | 0.0% |
Q1 2016 | $4,068,000 | -52.3% | 254,439 | -14.6% | 0.00% | -55.6% |
Q4 2015 | $8,527,000 | +1911.1% | 297,850 | +1897.5% | 0.01% | – |
Q3 2015 | $424,000 | -20.2% | 14,911 | +0.8% | 0.00% | -100.0% |
Q2 2015 | $531,000 | +63.9% | 14,787 | +165.2% | 0.00% | – |
Q1 2015 | $324,000 | +58.0% | 5,575 | +14.5% | 0.00% | – |
Q4 2014 | $205,000 | -92.3% | 4,868 | -92.9% | 0.00% | -100.0% |
Q3 2014 | $2,673,000 | -78.6% | 68,927 | -82.8% | 0.00% | -75.0% |
Q2 2014 | $12,481,000 | +109.1% | 399,663 | +177.4% | 0.01% | +100.0% |
Q1 2014 | $5,970,000 | -51.7% | 144,088 | -54.9% | 0.01% | -50.0% |
Q4 2013 | $12,364,000 | -12.0% | 319,398 | -20.5% | 0.01% | -14.3% |
Q3 2013 | $14,056,000 | +122.1% | 401,727 | -12.2% | 0.01% | +100.0% |
Q2 2013 | $6,330,000 | – | 457,406 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
GAM Holding AG | 83,940 | $745,000 | 0.03% |
Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |